Cargando…

Oncology Update: Anamorelin

BACKGROUND: Cancer cachexia is a catabolic syndrome associated with uncontrolled muscle breakdown. There may be associated fat loss. Occurring in high frequency in advanced cancer, it is an indicator of poor prognosis. Besides weight loss, patients experience a cluster of symptoms including anorexia...

Descripción completa

Detalles Bibliográficos
Autor principal:	Prommer, Eric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570113/ https://www.ncbi.nlm.nih.gov/pubmed/28855797 http://dx.doi.org/10.1177/1178224217726336

Ejemplares similares

Refractory Monomorphic Ventricular Tachycardia Induced by Anamorelin
por: Sakagami, Hiroaki, et al.
Publicado: (2022)

Anamorelin hydrochloride in the treatment of cancer anorexia–cachexia syndrome: design, development, and potential place in therapy
por: Graf, Solomon A, et al.
Publicado: (2017)

Appetite and food intake results from phase I studies of anamorelin
por: Blum, Robert A., et al.
Publicado: (2019)

Factors associated with early discontinuation of anamorelin in patients with cancer-associated cachexia
por: Tsukiyama, Ikuto, et al.
Publicado: (2023)

Evidence for partial pharmaceutical reversal of the cancer anorexia–cachexia syndrome: the case of anamorelin
por: Anker, Stefan D, et al.
Publicado: (2015)

Combination therapy with anamorelin and a myostatin inhibitor is advantageous for cancer cachexia in a mouse model
por: Hanada, Kako, et al.
Publicado: (2022)

First case report of anamorelin-induced fatal arrhythmia complicated by sinus arrest and refractory ventricular tachycardia
por: Kojima, Keisuke, et al.
Publicado: (2022)

Impact of the Extent of Weight Loss before Administration on the Efficacy of Anamorelin in Advanced Pancreatic Cancer Patients with Cachexia
por: Takeda, Tsuyoshi, et al.
Publicado: (2022)

Predictors of efficacy of anamorelin in patients with non‑small cell lung cancer and cachexia: A retrospective study
por: Ishioka, Yoshiko, et al.
Publicado: (2023)

An open-label clinical trial of the effects of age and gender on the pharmacodynamics, pharmacokinetics and safety of the ghrelin receptor agonist anamorelin
por: Leese, Philip T, et al.
Publicado: (2015)

Randomised placebo-controlled cross-over study examining the role of anamorelin in mesothelioma (The ANTHEM study): rationale and protocol
por: Hoon, Siao Nge, et al.
Publicado: (2020)

Efficacy and safety of anamorelin in patients with cancer cachexia: Post‐hoc subgroup analyses of a placebo‐controlled study
por: Takayama, Koichi, et al.
Publicado: (2022)

The efficacy and safety of anamorelin for patients with cancer-related anorexia/cachexia syndrome: a systematic review and meta-analysis
por: Taniguchi, Jumpei, et al.
Publicado: (2023)

Levorphanol: Revisiting an Underutilized Analgesic
por: Prommer, Eric
Publicado: (2014)

Midazolam: an essential palliative care drug
por: Prommer, Eric
Publicado: (2020)

Updates in oncology
por: Sculier, Jean-Paul, et al.
Publicado: (2014)

Efficacy of Anamorelin, a Novel Non-Peptide Ghrelin Analogue, in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) and Cachexia—Review and Expert Opinion
por: Currow, David C., et al.
Publicado: (2018)

Development of a Patient-Centered Framework for Oncology Clinicians to Address Uncertainty in Cancer Care During the COVID-19 Pandemic
por: Dhawan, Natasha, et al.
Publicado: (2020)

Update on radionuclide therapy in oncology
por: Nitipir, Cornelia, et al.
Publicado: (2017)

Updates in imaging in ocular oncology
por: Davila, Jose R., et al.
Publicado: (2019)

Intranasal fentanyl for pain control: current status with a focus on patient considerations
por: Prommer, Eric, et al.
Publicado: (2011)

Fentanyl transmucosal tablets: current status in the management of cancer-related breakthrough pain
por: Prommer, Eric, et al.
Publicado: (2012)

Anamorelin HCl (ONO-7643), a novel ghrelin receptor agonist, for the treatment of cancer anorexia-cachexia syndrome: preclinical profile
por: Pietra, Claudio, et al.
Publicado: (2014)

A multicenter, open‐label, single‐arm study of anamorelin (ONO‐7643) in advanced gastrointestinal cancer patients with cancer cachexia
por: Hamauchi, Satoshi, et al.
Publicado: (2019)

A case of squamous cell lung cancer treated with anamorelin in combination with a multidisciplinary collaborative approach for treating cancer cachexia
por: Oshima, Yuri, et al.
Publicado: (2022)

Nanotechnology and Drug Delivery: An Update in Oncology
por: Jones, Tait, et al.
Publicado: (2011)

Diffusion-Weighted Imaging in Oncology: An Update
por: Messina, Carmelo, et al.
Publicado: (2020)

Palliative treatment of malignant ascites: profile of catumaxomab
por: Ammouri, Lila, et al.
Publicado: (2010)

Anamorelin (ONO-7643) in Japanese patients with non-small cell lung cancer and cachexia: results of a randomized phase 2 trial
por: Takayama, Koichi, et al.
Publicado: (2016)

Supplementary Oral Anamorelin Mitigates Anorexia and Skeletal Muscle Atrophy Induced by Gemcitabine Plus Cisplatin Systemic Chemotherapy in a Mouse Model
por: Miyake, Makito, et al.
Publicado: (2020)

A multicenter, open‐label, single‐arm study of anamorelin (ONO‐7643) in patients with cancer cachexia and low body mass index
por: Naito, Tateaki, et al.
Publicado: (2022)

Metabolism Study of Anamorelin, a GHSR1a Receptor Agonist Potentially Misused in Sport, with Human Hepatocytes and LC-HRMS/MS
por: Gameli, Prince Sellase, et al.
Publicado: (2023)

Oncology Update
por: Gündüz, Kaan
Publicado: (2010)

ROMANA 3: a phase 3 safety extension study of anamorelin in advanced non-small-cell lung cancer (NSCLC) patients with cachexia
por: Currow, D., et al.
Publicado: (2017)

Effect of ghrelin and anamorelin (ONO-7643), a selective ghrelin receptor agonist, on tumor growth in a lung cancer mouse xenograft model
por: Northrup, R., et al.
Publicado: (2013)

Robotic prostatectomy: an update on functional and oncologic outcomes
por: Cozzi, Gabriele, et al.
Publicado: (2013)

PET Imaging in Neuro-Oncology: An Update and Overview of a Rapidly Growing Area
por: Verger, Antoine, et al.
Publicado: (2022)

Updating Perspectives on Meta-Analyses in the Field of Radiation Oncology
por: Shin, In-Soo, et al.
Publicado: (2021)

Phytotherapy in Integrative Oncology—An Update of Promising Treatment Options
por: Zimmermann-Klemd, Amy M., et al.
Publicado: (2022)

Advances in Radiation Oncology for Pancreatic Cancer: An Updated Review
por: Liu, Jason, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sllnhldegfrh4snqn9hgro0vkj